A specialized DNA methylation-based test for early detection and diagnosis of colorectal cancer. The test provides risk stratification and early screening capabilities for colorectal malignancies.
Manufactured by
China
Singlera Genomics is a China-based manufacturer of in vitro diagnostic (IVD) reagents and instruments specializing in DNA methylation-based cancer early detection and liquid biopsy testing. The company produces diagnostic products for multiple cancer types including colorectal, liver, gastric, esophageal, and pancreatic cancers, with manufacturing facilities in Yangzhou and Wuxi. Singlera holds ISO 13485 certification, CAP accreditation, US CLIA laboratory certification, and is designated as a National High-tech Enterprise in China.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Clinomics Europe Kft.
Hungary · 1 relevant product
Acon Biotech (Hangzhou) Co., Ltd.
China · 3 relevant products
Biomerica, Inc.
United States · 1 relevant product
Camtech Diagnostics Pte Ltd
Singapore · 1 relevant product
BioChain (Beijing) Science & Technology. Inc.
China · 12 relevant products
GeneCker Co., Ltd.
South Korea · 1 relevant product
ACON Laboratories, Inc.
United States · 1 relevant product
STRATEC/Diatron
Germany · 2 relevant products
i Med Laboratories Co., Ltd.
Thailand · 1 relevant product
Wuhan YZY Medical Science and Technology Co.,Ltd.
China · 3 relevant products
46 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →9 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 93 closest product alternatives
Clinomics Europe Kft. · Hungary
Multi-gene methylation detection test for colorectal cancer screening and risk assessment. Uses advanced liquid biopsy technology to identify epigenetic biomarkers associated with colorectal malignancy. Enables non-invasive early detection and personalized patient stratification for clinical decision-making.
Acon Biotech (Hangzhou) Co., Ltd. · China
Molecular diagnostic test for cancer detection and tumor marker analysis. Supports early detection of various cancer types.
Biomerica, Inc. · United States
An at-home diagnostic test for screening colorectal cancer through fecal occult blood detection. Provides laboratory accuracy results in minutes from home with privacy and convenience.
Camtech Diagnostics Pte Ltd · Singapore
Self-sampling colon cancer screening test designed for point-of-care diagnostics. This non-invasive testing solution enables early detection of colorectal cancer through convenient at-home sample collection, supporting mass screening programs and clinical diagnostic workflows.
BioChain (Beijing) Science & Technology. Inc. · China
Advanced early detection test for lung cancer screening utilizing molecular diagnostic technology. This in-development product represents the company's expansion into early detection for pulmonary malignancies. The test is designed for high-risk population screening and clinical intervention.
GeneCker Co., Ltd. · South Korea
Molecular diagnostic test using CRISPR/Cas9 technology to identify and amplify mutant DNA sequences in patient samples. Provides standardized detection and quantification of cancer-related genetic mutations.
ACON Laboratories, Inc. · United States
Qualitative screening immunoassay for the detection of cancer markers. Designed for reliable and accessible cancer risk assessment in point-of-care settings.
BioChain (Beijing) Science & Technology. Inc. · China
Diagnostic test for early detection of cognitive impairment and neurodegenerative disease risk. This biomarker-based test supports early intervention strategies for age-related cognitive disorders. The product aligns with research collaborations in epigenetic disease markers.
BioChain (Beijing) Science & Technology. Inc. · China
Biomarker-based diagnostic test for early detection and screening of diabetes mellitus. This test supports the company's focus on early identification and intervention in metabolic diseases. The product is part of comprehensive chronic disease screening offerings.
STRATEC/Diatron · Germany
In-vitro diagnostic test for detecting tumor markers and cancer-related antigens in blood and other biological samples. The test aids in cancer screening, diagnosis, and treatment monitoring.
STRATEC/Diatron · Germany
Diagnostic test for identifying genetic disorders through molecular analysis of biological samples. The test can detect chromosomal abnormalities and inherited genetic conditions.
i Med Laboratories Co., Ltd. · Thailand
Diagnostic test for detection of cancer biomarkers in blood and body secretions. Identifies biomolecules produced and released by cancer cells for screening and monitoring purposes.
81 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products